[rev_slider 2016-recf-session-2]

SESSION 2 “Ethics & Compliance Metrics & Reporting”

Ethics and compliance reporting arises as part of the global need to ensure that businesses are proactively tackling their internal and external vulnerabilities. It has been argued by various academic and business specialists that ethics and compliance reporting enhances one company’s reputation and positioning. European Union have emphasized more and more this aspect by adopting a Directive on non-financial reporting (Directive 2014/95/UE) and other on anti-money laundering and transparency of listed companies, by issuing a recommendation concerning corporate governance reporting (Recommendation 2014/208/EU) and consulting on a Directive on corporate governance. At the same time, international organisations like OECD, WEF, IMF and WB have been active promoters of enhanced transparency in private and public sectors.

This forth session will deal with ethics and compliance audit, non-financial reporting and tools and frameworks available for large, middle and small enterprises, as well as practical experience from Romanian pioneers in the field of corporate transparency.


Session Chair: Laura Florea (Point Public Affairs)

Forum Agenda | February 11, 2016

08.30.–09.00.   Registration & Welcome Coffee
10.30.–10.45.   Coffee Break
10.45.–12.15.   SESSION 2 “Ethics & Compliance Metrics & Reporting”
12.15.–13.30.   Networking Lunch
15.00.–15.15.   Coffee Break
16.45.–17.15.   CONCLUDING REMARKS


Oana Raluca Banateanu



Mind the Gap. Risk to Integrity

General Manager – Business Development Division
Omniasig Vienna Insurance Group

1. Insurance – the integrity outcome: What are the non-capital needs of an insurer? Which are the client needs? What the insurer really offers? What is the context of the business relation?

2. Mind the gap – KPI’s, a danger to integrity? Which are the scenarios? What to do?

3. Business practice paradigms – fair or politically correct? How crisis situation make the difference between the two? Which are the risks?

4. Organisms or organizations – integrity impact: Feelings or judgment?

Siemens’s Compliance System: how to set a benchmark for organisational integrity in a complex environment

Regional Compliance Officer
Siemens Romania

The current Siemens Compliance System was developed in 2007 and 2008, initially in response to criminal investigations undertaken by the Office of the Public Prosecutor in Munich, the US Securities and Exchange Commission, the US Department of Justice and numerous other investigating authorities worldwide.
The Compliance System is based on a clearly defined system, into which all Group compliance measures must fit The Siemens Compliance Organization and the key elements of the Siemens Compliance System within this structure are outlined in the following pillars: Prevent – Detect – Respond.
Siemens regularly publishes compliance indicators and further information on compliance development at Siemens through Annual Reports and additional Sustainability information to the Siemens Annual Reports. They also make the current indicators available in the Compliance section of the Siemens Global Website where we also provide the index of company information according to the Anti-Corruption Reporting Guidance of the UN Global Compact and Transparency International. The Siemens financial reports contain information on legal proceedings.

Transparency – EFPIA Changes Codes of Practice in Pharmaceutical Industry

Country Head of Law, Patents and Compliance
Bayer, Country Group Romania/Bulgaria/Moldova

This presentation is focused on the changes of the EFPIA Codes of Ethics, which generated an important shift in the organisational culture in respect to the application of Compliance policies in Life Sciences domain. In the first part, it will deal with the situation in the Healthcare domain before the implementation of the new European compliance policies, while in the second it will describe the novel elements of the policies and their effects. More precisely, the main topic of the industry, i.e., the relations between pharmaceutical companies and healthcare professional, will be evaluated from an ethical point of view. In connection with this, the presentation will also approach topics like distribution of promotions, transparency of promotions, sponsorship/donations/grants that support healthcare or research, and prohibition of gifts and physician financial transparency reports. For the Healthcare Industry, this moment can be considered as a kickoff for implementing a real European Sunshine Act.

Ethics & Compliance Reporting in Non-Financial Transparency Era. Challenges and Approaches

Senior Ethics & Compliance Consultant
Centre for Advanced Research in Management and Applied Ethics

For many people, Directive 2014/95/UE represents the beginning of a new era in corporate reporting because it sets a clear obligation for European large enterprises and groups to report on their non-financial results. The same people tend to disregard the fact we are part of a complex evolution in corporate responsibility and accountability, which led, for now, to two mentalities (Financial and Non-Financial), but will shift more and more towards Integrated Reporting. They also disregard the fact that the new ideology in CSR / Sustainability — “Report or Boycott” — is based on a fallacy that erodes the very idea of organisational integrity.
This presentation is focused in particular on the challenges and traps in corporate non-financial reporting, trying to offer a glimpse in the complex issue of supply chain transparency. The integrity of multinationals, especially those with vast multi-stratified supply chains, is jeopardized by the failed approach to the whole issue of corporate responsibility and accountability.